These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 7106193)

  • 1. Choline and physostigmine enhance haloperidol-induced HVA and DOPAC accumulation.
    Millington WR; Wurtman RJ
    Eur J Pharmacol; 1982 Jun; 80(4):431-4. PubMed ID: 7106193
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhancement of haloperidol-induced increase in rat striatal or mesolimbic 3,4-dihydroxyphenylacetic acid and homovanillic acid by pretreatment with chronic methamphetamine.
    Toru M; Mataga N; Takashima M; Nishikawa T
    Psychopharmacology (Berl); 1981; 74(4):316-20. PubMed ID: 6794073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Developmental change in striatal concentration of homovanillic acid and 3,4-dihydroxyphenylacetic acid in response to apomorphine and haloperidol treatment.
    Nomura Y; Komori T; Okuda S; Segawa T
    Arch Int Pharmacodyn Ther; 1979 Jan; 237(1):25-30. PubMed ID: 485682
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of extracellular DOPAC, HVA and 5-HIAA in rat striatum in vivo by differential pulse voltammetry: effect of phencyclidine, haloperidol and their coadministration.
    Crespi F; Keane PE
    Pharmacol Res Commun; 1987 Sep; 19(9):639-49. PubMed ID: 2448834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytidine(5')diphosphocholine enhances the ability of haloperidol to increase dopamine metabolites in the striatum of the rat and to diminish stereotyped behavior induced by apomorphine.
    Agut J; Coviella IL; Wurtman RJ
    Neuropharmacology; 1984 Dec; 23(12A):1403-6. PubMed ID: 6543245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involvement of striatal dopamine, homovanillic acid and 3,4-dihydroxyphenylacetic acid in the hypothermia and catalepsy induced by haloperidol.
    Massotti M
    Pharmacol Res Commun; 1977 Apr; 9(4):381-9. PubMed ID: 559310
    [No Abstract]   [Full Text] [Related]  

  • 7. Acute choline administration in rat and mouse: no effect on dopamine metabolism in brain.
    Flentge F; Postema F; Medema HM; Van den Berg CJ
    Life Sci; 1981 Jul; 29(4):331-5. PubMed ID: 7278490
    [No Abstract]   [Full Text] [Related]  

  • 8. Long-term decreases in striatal dopamine, 3,4-dihydroxyphenylacetic acid, and homovanillic acid after a single injection of amphetamine in iprindole-treated rats: time course and time-dependent interactions with amfonelic acid.
    Steranka LR
    Brain Res; 1982 Feb; 234(1):123-36. PubMed ID: 7059818
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 3-Methoxytyramine and different neuroleptics: dissociation from HVA and DOPAC.
    Groppetti A; Parenti M; Galli CL; Bugatti A; Cattabeni F; Di Giulio AM; Racagni G
    Life Sci; 1978 Oct; 23(17-18):1763-8. PubMed ID: 31531
    [No Abstract]   [Full Text] [Related]  

  • 10. Differential effects of certain dopaminergic drugs on the striatal concentration of dopamine metabolites, with special reference to 3-methoxytramine.
    Ponzio F; Achilli G; Perego C; Algeri S
    Neurosci Lett; 1981 Nov; 27(1):61-7. PubMed ID: 7329624
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does brain 3,4-dihydroxyphenylacetic acid reflect dopamine release?
    Soares-da-Silva P
    J Pharm Pharmacol; 1987 Feb; 39(2):127-9. PubMed ID: 2881997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential effect of acute and chronic haloperidol administration on dopamine turnover in rat nigrostriatal and retinal dopaminergic neurons.
    Melamed E; Durst R; Frucht Y; Globus M
    Eur J Pharmacol; 1983 May; 89(3-4):279-82. PubMed ID: 6873163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of the synthesis and metabolism of striatal dopamine after disruption of nerve conduction in the medial forebrain bundle.
    Commissiong JW; Slimovitch C; Toffano G
    Br J Pharmacol; 1990 Apr; 99(4):741-9. PubMed ID: 2361171
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of probenecid on endogenous and exogenous 3,4-dihydroxyphenylacetic acid and homovanillic acid in the rat brain.
    Broch OJ
    Eur J Pharmacol; 1976 Sep; 39(1):33-40. PubMed ID: 964303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Behavioral activation in rats increases striatal dopamine metabolism measured by dialysis perfusion.
    Salamone JD; Keller RW; Zigmond MJ; Stricker EM
    Brain Res; 1989 May; 487(2):215-24. PubMed ID: 2786443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Striatal dopamine metabolism increases during long-term haloperidol administration in rats but shows tolerance in response to acute challenge with raclopride.
    See RE
    Neurosci Lett; 1991 Aug; 129(2):265-8. PubMed ID: 1720879
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of drugs on striatal and limbic homovanillic acid concentration in the rat brain.
    Westerink BH; Korf J
    Eur J Pharmacol; 1975 Aug; 33(1):31-40. PubMed ID: 126169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention by (+/-)-8-hydroxy-2-(di-n-propylamino)tetralin of both catalepsy and the rises in rat striatal dopamine metabolism caused by haloperidol.
    Andersen HL; Kilpatrick IC
    Br J Pharmacol; 1996 May; 118(2):421-7. PubMed ID: 8735647
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lithium dissociates haloperidol-induced behavioral supersensitivity from reduced dopac increase in rat striatum.
    Meller E; Friedman E
    Eur J Pharmacol; 1981 Nov; 76(1):25-9. PubMed ID: 7318921
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of changes in locomotor activity with striatal homovanillic acid and 3,4-dihydroxyphenylacetic acid concentrations following the bilateral intranigral injection of dopamine agonist drugs in rats.
    Kelly E; Jenner P; Marsden CD
    J Pharm Pharmacol; 1987 Mar; 39(3):196-202. PubMed ID: 2883284
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.